Head of Regulatory and Peri-registration Activities
As Head of Regulatory and Peri-registration Activities, Bob oversees the regulatory aspects of TranScrip’s projects.
His regulatory experience includes leadership of many meetings with FDA, EMA and PDMA. He has been on the board of the ICH working party on the Clinical Trial Report, and was a member of a joint NCI/FDA/ASCO working party on breast cancer prevention. He brings to TranScrip over 30 years of experience, principally in Astra Zeneca and latterly at Celtic Pharma in Clinical and Regulatory Affairs.